Keisha L. Gibson

7.5k total citations · 1 hit paper
53 papers, 1.1k citations indexed

About

Keisha L. Gibson is a scholar working on Nephrology, Pathology and Forensic Medicine and Speech and Hearing. According to data from OpenAlex, Keisha L. Gibson has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Nephrology, 10 papers in Pathology and Forensic Medicine and 7 papers in Speech and Hearing. Recurrent topics in Keisha L. Gibson's work include Renal Diseases and Glomerulopathies (32 papers), Chronic Kidney Disease and Diabetes (15 papers) and Autoimmune Bullous Skin Diseases (7 papers). Keisha L. Gibson is often cited by papers focused on Renal Diseases and Glomerulopathies (32 papers), Chronic Kidney Disease and Diabetes (15 papers) and Autoimmune Bullous Skin Diseases (7 papers). Keisha L. Gibson collaborates with scholars based in United States, Netherlands and Canada. Keisha L. Gibson's co-authors include Debbie S. Gipson, María Ferris, Laura Lisk, Samir V. Parikh, Robert B. Huizinga, Y K Onno Teng, Ellen M. Ginzler, Simrat Randhawa, Cristina Arriens and Dawn J. Caster and has published in prestigious journals such as The Lancet, Neurology and PEDIATRICS.

In The Last Decade

Keisha L. Gibson

50 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

2021 299 citations Brad H. Rovin, Y K Onno Teng et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keisha L. Gibson United States	16	594	437	207	144	110	53	1.1k
Charles R. Swanepoel South Africa	21	1.0k 1.8×	212 0.5×	74 0.4×	118 0.8×	40 0.4×	62	1.6k
K.-M. Chow Hong Kong	17	361 0.6×	324 0.7×	266 1.3×	32 0.2×	47 0.4×	38	1.1k
Nada Alachkar United States	23	907 1.5×	59 0.1×	393 1.9×	114 0.8×	93 0.8×	56	1.8k
Michael E. Falkenhain United States	17	503 0.8×	172 0.4×	78 0.4×	42 0.3×	257 2.3×	21	1.6k
Emanuel Zitt Austria	21	587 1.0×	101 0.2×	36 0.2×	232 1.6×	39 0.4×	77	1.2k
Vimal K. Derebail United States	26	711 1.2×	189 0.4×	122 0.6×	148 1.0×	10 0.1×	95	1.9k
Nurhan Seyahi Türkiye	17	270 0.5×	272 0.6×	82 0.4×	40 0.3×	26 0.2×	107	1.3k
Sharon Nessim United States	21	104 0.2×	392 0.9×	214 1.0×	115 0.8×	55 0.5×	33	1.5k
Mandar Apte United States	16	96 0.2×	786 1.8×	415 2.0×	144 1.0×	48 0.4×	17	1.0k
A. J. Taggart United Kingdom	18	137 0.2×	624 1.4×	110 0.5×	105 0.7×	22 0.2×	36	1.1k

Countries citing papers authored by Keisha L. Gibson

Since Specialization

Citations

This map shows the geographic impact of Keisha L. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisha L. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisha L. Gibson more than expected).

Fields of papers citing papers by Keisha L. Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisha L. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisha L. Gibson. The network helps show where Keisha L. Gibson may publish in the future.

Co-authorship network of co-authors of Keisha L. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Keisha L. Gibson. A scholar is included among the top collaborators of Keisha L. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisha L. Gibson. Keisha L. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Floege, Jürgen, Keisha L. Gibson, Marina Vivarelli, et al.. (2025). Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children. Kidney International. 107(5). 806–808. 2 indexed citations

Smith, Abigail R., Chia-shi Wang, Bruce Robinson, et al.. (2025). New Index Demonstrates Association between Social Vulnerability, Environmental Burden, and Kidney Failure Risk among Individuals with Glomerular Disease. Clinical Journal of the American Society of Nephrology. 20(4). 555–562.

Gibson, Keisha L., et al.. (2024). Minimal Change Disease. PubMed. 31(4). 267–274. 2 indexed citations

Saxena, Amit, Ellen M. Ginzler, Keisha L. Gibson, et al.. (2023). Safety and Efficacy of Long‐Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial. Arthritis & Rheumatology. 76(1). 59–67. 49 indexed citations

Wang, Linda, Dorey A. Glenn, Katherine R. Tuttle, et al.. (2023). Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. BMC Nephrology. 24(1). 30–30. 4 indexed citations

Rheault, Michelle N., Heather M. McLaughlin, Lauren E. Blake, et al.. (2023). COL4A gene variants are common in children with hematuria and a family history of kidney disease. Pediatric Nephrology. 38(11). 3625–3633. 5 indexed citations

Vivarelli, Marina, Keisha L. Gibson, Aditi Sinha, & Olivia Boyer. (2023). Childhood nephrotic syndrome. The Lancet. 402(10404). 809–824. 34 indexed citations

Bjornstad, Erica C., Rhys Evans, Amy K. Mottl, et al.. (2023). Saliva urea nitrogen dipsticks to predict acute kidney injury in Malawian trauma patients. 26(1). 1 indexed citations

Glenn, Dorey A., Jarcy Zee, Sarah Mansfield, et al.. (2022). Immunosuppression Exposure and Risk of Infection-Related Acute Care Events in Patients With Glomerular Disease: An Observational Cohort Study. Kidney Medicine. 4(11). 100553–100553. 2 indexed citations

10.

Brady, Tammy M., Kevin Meyers, Michelle M. O’Shaughnessy, et al.. (2021). Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies. The Nephron journals/Nephron journals. 145(3). 245–255. 11 indexed citations

11.

Bjornstad, Erica C., Charles K. Munthali, Amy K. Mottl, et al.. (2021). High risk of acute kidney injury in Malawian trauma patients: a prospective observational cohort study. BMC Nephrology. 22(1). 354–354. 7 indexed citations

12.

Agrawal, Shipra, Michael E. Brier, Bryce A. Kerlin, et al.. (2021). Plasma Cytokine Profiling to Predict Steroid Resistance in Pediatric Nephrotic Syndrome. Kidney International Reports. 6(3). 785–795. 8 indexed citations

13.

Glenn, Dorey A., Michelle M. O’Shaughnessy, Yichun Hu, et al.. (2020). Infection-Related Acute Care Events among Patients with Glomerular Disease. Clinical Journal of the American Society of Nephrology. 15(12). 1749–1761. 13 indexed citations

14.

Watkins, Sandra, Marva Moxey‐Mims, Patrick E. Gipson, Debbie S. Gipson, & Keisha L. Gibson. (2020). Therapeutic approach to FSGS in children. UNC Libraries.

15.

Gooding, Jessica, Shipra Agrawal, Susan McRitchie, et al.. (2019). Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics. Kidney International Reports. 5(1). 81–93. 26 indexed citations

16.

Gibson, Keisha L., Dorey A. Glenn, & María Ferris. (2015). Back to the Future: Therapies for Idiopathic Nephrotic Syndrome. Blood Purification. 39(1-3). 105–109. 3 indexed citations

17.

Ferris, María, Karina Javalkar, Sarah Cohen, et al.. (2015). Self-Management and Transition Among Adolescents/Young Adults with Chronic or End-Stage Kidney Disease. Blood Purification. 39(1-3). 99–104. 24 indexed citations

18.

Ferris, María, E.A. Ba, John D. Mahan, et al.. (2014). Wanted: pediatric nephrologists! — why trainees are not choosing pediatric nephrology. Renal Failure. 36(8). 1340–1344. 15 indexed citations

19.

Gibson, Keisha L., Debbie S. Gipson, & Susan F. Massengill. (2009). Renal Manifestations of Systemic Illness in Children. Seminars in Nephrology. 29(4). 360–369. 1 indexed citations

20.

Gipson, Debbie S., Keisha L. Gibson, Patrick E. Gipson, Sandra Watkins, & Marva Moxey‐Mims. (2006). Therapeutic approach to FSGS in children. Pediatric Nephrology. 22(1). 28–36. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact